153 related articles for article (PubMed ID: 29541226)
1. SOX2 and SOX12 are predictive of prognosis in patients with clear cell renal cell carcinoma.
Gu W; Wang B; Wan F; Wu J; Lu X; Wang H; Zhu Y; Zhang H; Shi G; Dai B; Ye D
Oncol Lett; 2018 Apr; 15(4):4564-4570. PubMed ID: 29541226
[TBL] [Abstract][Full Text] [Related]
2. ITGA2B and ITGA8 are predictive of prognosis in clear cell renal cell carcinoma patients.
Lu X; Wan F; Zhang H; Shi G; Ye D
Tumour Biol; 2016 Jan; 37(1):253-62. PubMed ID: 26198048
[TBL] [Abstract][Full Text] [Related]
3. Identification of SOX6 and SOX12 as Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma: A Retrospective Study Based on TCGA Database.
Lyu X; Zhang X; Sun LB; Cao XM; Zhang XH
Dis Markers; 2021; 2021():7190301. PubMed ID: 34868396
[TBL] [Abstract][Full Text] [Related]
4. NUDT expression is predictive of prognosis in patients with clear cell renal cell carcinoma.
Wang Y; Wan F; Chang K; Lu X; Dai B; Ye D
Oncol Lett; 2017 Nov; 14(5):6121-6128. PubMed ID: 29113256
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of D-lactate dehydrogenase in patients with clear cell renal cell carcinoma.
Wang Y; Li G; Wan F; Dai B; Ye D
Oncol Lett; 2018 Jul; 16(1):866-874. PubMed ID: 29963157
[TBL] [Abstract][Full Text] [Related]
6. NR1H3 Expression is a Prognostic Factor of Overall Survival for Patients with Muscle-Invasive Bladder Cancer.
Wu J; Wan F; Sheng H; Shi G; Shen Y; Lin G; Dai B; Zhu Y; Ye D
J Cancer; 2017; 8(5):852-860. PubMed ID: 28382148
[TBL] [Abstract][Full Text] [Related]
7. Correlation of sex-determining region Y-box 30 with tumor characteristics and its prognostic value in breast cancer.
Peng H; Luo Y; Wu J; Yin W
J Clin Lab Anal; 2020 Jun; 34(6):e23232. PubMed ID: 32157740
[TBL] [Abstract][Full Text] [Related]
8. FOXO4 and FOXD3 are predictive of prognosis in gastric carcinoma patients.
Li J; Jiang Z; Han F; Liu S; Yuan X; Tong J
Oncotarget; 2016 May; 7(18):25585-92. PubMed ID: 27027443
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation of soluble carrier family expression signature for predicting poor outcome of renal cell carcinoma.
Fangning W; Chunguang M; Hailiang Z; Guohai S; Yao Z; Bo D; Yijun S; Yiping Z; Dingwei Y
J Cancer; 2017; 8(11):2010-2017. PubMed ID: 28819401
[TBL] [Abstract][Full Text] [Related]
10. Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model.
de Velasco G; Culhane AC; Fay AP; Hakimi AA; Voss MH; Tannir NM; Tamboli P; Appleman LJ; Bellmunt J; Kimryn Rathmell W; Albiges L; Hsieh JJ; Heng DY; Signoretti S; Choueiri TK
Oncologist; 2017 Mar; 22(3):286-292. PubMed ID: 28220024
[TBL] [Abstract][Full Text] [Related]
11. A Panel of Four-lncRNA Signature as a Potential Biomarker for Predicting Survival in Clear Cell Renal Cell Carcinoma.
Liu H; Ye T; Yang X; Lv P; Wu X; Zhou H; Zeng J; Tang K; Ye Z
J Cancer; 2020; 11(14):4274-4283. PubMed ID: 32368310
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma.
Fan B; Wang W; Zhang X; Sun M; Wang X; Chen Z; Liu W; Wang Q; Yu N; Li X
BMC Cancer; 2019 Jun; 19(1):534. PubMed ID: 31159774
[TBL] [Abstract][Full Text] [Related]
13. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
[TBL] [Abstract][Full Text] [Related]
14. Forkhead-box series expression network is associated with outcome of clear-cell renal cell carcinoma.
Jia Z; Wan F; Zhu Y; Shi G; Zhang H; Dai B; Ye D
Oncol Lett; 2018 Jun; 15(6):8669-8680. PubMed ID: 29805604
[TBL] [Abstract][Full Text] [Related]
15. Clinical and Survival Impact of Sex-Determining Region Y-Box 2 in Colorectal Cancer: An Integrated Analysis of the Immunohistochemical Study and Bioinformatics Analysis.
Song K; Hao J; Ge Z; Chen P
J Oncol; 2020; 2020():3761535. PubMed ID: 32104175
[TBL] [Abstract][Full Text] [Related]
16. SOX12 expression is associated with progression and poor prognosis in human breast cancer.
Xu J; Zhang J; Li L; Mao J; You T; Li Y
Am J Transl Res; 2020; 12(12):8162-8174. PubMed ID: 33437389
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a robust multigene signature as an aid to predict early relapse in stage I-III clear cell and papillary renal cell cancer.
Cao DL; Dai WX; Huang YQ; Yu LJ; Wu JL; Shi GH; Zhang HL; Zhu Y; Dai B; Ye DW
J Cancer; 2020; 11(5):997-1007. PubMed ID: 31956346
[No Abstract] [Full Text] [Related]
18. [Expression of transcription factor SOX12 in lung adenocarcinoma and its clinical significance].
Li L; Zhang T; Chen Y; Song J; Meng Y; Liu S; Xie J
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Feb; 39(2):186-191. PubMed ID: 30890507
[TBL] [Abstract][Full Text] [Related]
19. Integrin and gene network analysis reveals that ITGA5 and ITGB1 are prognostic in non-small-cell lung cancer.
Zheng W; Jiang C; Li R
Onco Targets Ther; 2016; 9():2317-27. PubMed ID: 27143927
[TBL] [Abstract][Full Text] [Related]
20. Construction and Validation of a 9-Gene Signature for Predicting Prognosis in Stage III Clear Cell Renal Cell Carcinoma.
Wu J; Jin S; Gu W; Wan F; Zhang H; Shi G; Qu Y; Ye D
Front Oncol; 2019; 9():152. PubMed ID: 30941304
[No Abstract] [Full Text] [Related]
[Next] [New Search]